Missing/wrong data?
Log in to edit
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial
scientific article published on 13 November 2017
Author/s
author: Suzette Delaloge, Robert Šeparović, Kenichi Inoue, Bent Ejlertsen, Bruno Coudert, Hiroji Iwata, Beverly Moy
Work details
Publication date
November 13, 2017
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.